Samuel Oberstein
Obstetrics & Gynecology · Miami Shores, FLNPI 1508987991
Payments from drug & device makers
What this record shows
That places this record below the midpoint for obstetrics & gynecology clinicians in FL, where the typical reported total is $820.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$1,362,213in research payments, 2019–2025
Across 82 payments — averaging $16,612 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$333K
- F. Hoffmann-la Roche AG$261K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$241K
- Eli Lilly$145K
- Incyte Corporation$100K
- Mylan Pharmaceuticals Inc.$97K
- plus $185K from 4 others
How this compares
$0 in reported general payments places this provider in the 0th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Miami Shores
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.